As of 2025-07-11, the Intrinsic Value of Microbix Biosystems Inc (MBX.TO) is 0.93 CAD. This MBX.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.30 CAD, the upside of Microbix Biosystems Inc is 210.40%.
The range of the Intrinsic Value is 0.60 - 2.48 CAD
Based on its market price of 0.30 CAD and our intrinsic valuation, Microbix Biosystems Inc (MBX.TO) is undervalued by 210.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 0.60 - 2.48 | 0.93 | 210.4% |
| DCF (Growth 10y) | 0.81 - 3.24 | 1.24 | 314.4% |
| DCF (EBITDA 5y) | 0.59 - 0.64 | 0.61 | 104.7% |
| DCF (EBITDA 10y) | 0.70 - 0.81 | 0.75 | 150.3% |
| Fair Value | 0.06 - 0.06 | 0.06 | -81.48% |
| P/E | 0.18 - 0.26 | 0.22 | -25.3% |
| EV/EBITDA | 0.30 - 0.30 | 0.30 | -0.3% |
| EPV | 0.16 - 0.20 | 0.18 | -40.5% |
| DDM - Stable | 0.14 - 0.86 | 0.50 | 65.8% |
| DDM - Multi | 0.58 - 2.82 | 0.96 | 221.0% |
| Market Cap (mil) | 42.24 |
| Beta | -0.20 |
| Outstanding shares (mil) | 140.80 |
| Enterprise Value (mil) | 33.05 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.40% |
| Cost of Debt | 5.00% |
| WACC | 6.20% |